receptor agonists - Robuta Search

https://www.epo.org/en/boards-of-appeal/decisions/t121366eu1 T 1366/12 (Guanylate cyclase receptor agonists/SYNERGY) of 04.06.2013 guanylate cyclase receptor agonists https://www.techtarget.com/pharmalifesciences/news/366606207/GLP-1-Receptor-Agonists-Reduce-24-Hour-Ambulatory-Blood-Pressure GLP-1 Receptor Agonists Reduce 24-Hour Ambulatory Blood Pressure | TechTarget Data from the SURMOUNT-1 study on tirzepatide revealed that it can reduce 24-hour ambulatory blood pressure. receptor agonists blood pressure glp reduce https://www.healthday.com/healthpro-news/mental-health/glucagon-like-peptide-1-receptor-agonists-may-be-treatment-for-alcohol-use-disorder Glucagon-Like Peptide-1 Receptor Agonists May Aid Alcohol Use Disorder Glucagon-like peptide-1 receptor agonists may be a potential novel treatment for alcohol use disorder. receptor agonists alcohol use glucagon like peptide https://erowid.org/references/refs_view.php?ID=6185&S=glutamate Erowid.org: Erowid Reference 6185 : Cannabinoid receptor agonists inhibit glutamatergic synaptic... The Index page for the reference article: Shen M, Piser TM, Seybold VS, Thayer SA Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in... cannabinoid receptor agonists reference inhibit synaptic https://www.jci.org/articles/view/167952 JCI - Dual gut hormone receptor agonists for diabetes and obesity receptor agonists for diabetes jci dual gut https://pmc.ncbi.nlm.nih.gov/articles/PMC8193264/ GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential - PMC Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure. Some... receptor agonists therapeutic potential glp https://www.jci.org/articles/view/194745/table/1 JCI - The promise of GLP-1 receptor agonists for neurodegenerative diseases the promise receptor agonists jci glp https://www.merckvetmanual.com/pharmacology/growth-promotants-and-production-enhancers/use-of-beta-adrenergic-receptor-agonists-in-animals Use of Beta-Adrenergic Receptor Agonists in Animals - Pharmacology - Merck Veterinary Manual Learn about the veterinary topic of Use of Beta-Adrenergic Receptor Agonists in Animals. Find specific details on this topic and related topics from the Merck... adrenergic receptor agonists https://www.news-medical.net/news/20240909/GLP-1-receptor-agonists-show-promise-in-treating-substance-use-disorders.aspx GLP-1 receptor agonists show promise in treating substance use disorders Sep 9, 2024 - A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study... receptor agonists substance use glp show https://www.rti.org/publication/discovery-arylsulfonamides-dual-orexin-receptor-agonists Discovery of arylsulfonamides as dual orexin receptor agonists | RTI Loss of orexin-producing neurons results in narcolepsy with cataplexy, and orexin agonists have been shown to increase wakefulness and alleviate narcolepsy... discovery of receptor agonists dual rti https://www.jci.org/articles/view/194745/figure/2 JCI - The promise of GLP-1 receptor agonists for neurodegenerative diseases the promise receptor agonists jci glp https://www.sciencedaily.com/releases/2014/12/141210162324.htm Peroxisome proliferator-activated receptor agonists may treat alcohol dependence | ScienceDaily Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins that regulate the expression of genes. PPAR agonists, which activate PPARs,... receptor agonists alcohol dependence peroxisome activated may https://www.hmpgloballearningnetwork.com/site/pulmonology/qas/rethinking-osa-management-glp-1-receptor-agonists-part-2 Rethinking OSA Management With GLP-1 Receptor Agonists: Part 2 Ali El Sohl, MD, professor, University of Buffalo, offers further thoughts on the findings of his narrative review exploring GLP-1 receptor agonists (GLP-1... receptor agonists rethinking osa management glp https://www.epo.org/de/boards-of-appeal/decisions/w990020eu1 W 0020/99 (Receptor agonists/NEDERLANDSE T.N.O.) vom 10.10.2000 receptor agonists https://www.jci.org/articles/view/194745/figure/3 JCI - The promise of GLP-1 receptor agonists for neurodegenerative diseases the promise receptor agonists jci glp https://noti.st/topics/receptor-agonists Presentations about Receptor agonists on Notist Presentations and videos about Receptor Agonists on Notist, the portfolio site for public speakers. receptor agonists presentations notist https://www.ebi.ac.uk/chembl/explore/document/CHEMBL1153343 Document: Liver X receptor agonists with selectivity for LXRbeta;... Report card for Document Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides. (CHEMBL1153343).... receptor agonists document liver x selectivity https://pmc.ncbi.nlm.nih.gov/articles/PMC4216654/ Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists - PMC Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial... cardiovascular effects receptor agonists glucagon like https://pmc.ncbi.nlm.nih.gov/articles/PMC12421399/ Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future... Obesity is a global pandemic that has been threatening the worldwide population. It has been reported to be associated with an increase in the risk of chronic... receptor agonists https://pmc.ncbi.nlm.nih.gov/articles/PMC12444648/ Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists - PMC How do bariatric surgery and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compare as obesity treatments regarding weight loss, ongoing costs, and... obesity treatment bariatric surgery receptor agonists https://www.mdpi.com/1420-3049/28/7/3063 Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A Cardiovascular ailments are a major cause of mortality where over 1.3 billion people suffer from hypertension leading to heart-disease related deaths. Snake... https://pmc.ncbi.nlm.nih.gov/articles/PMC5630073/?blog_tag=Microdose%2Cno-excerpt%2Csemaglutide&blog_category=Medications+%26+treatments%2CWeight+management Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional... Nonadherence to glucagon-like peptide-1 receptor agonists (GLP1 RAs) is relatively common among patients with type 2 diabetes mellitus (T2DM). This study... https://www.preprints.org/manuscript/202506.0860 Perioperative Management of Patients on GLP-1 Receptor Agonists: Clinical Implications and Best... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for type 2 diabetes mellitus (T2DM), obesity, and cardiovascular risk... https://elifesciences.org/articles/25492v1 Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses | eLife D-serine has a major role in the regulation of NMDA receptors not only contributing to its activation as the receptors co-agonist, but also by regulating... nmda receptor https://pmc.ncbi.nlm.nih.gov/articles/PMC12361690/ Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists - PMC This systematic review evaluates the long-term efficacy and safety of GLP-1 receptor agonists in the management of obesity, focusing on data from high-quality... https://pmc.ncbi.nlm.nih.gov/articles/PMC6928920/ Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm... Diabetic nephropathy (DN) is one of the most perilous side effects of diabetes mellitus type 1 and type 2 (T1DM and T2DM).). It is known that sodium/glucose... https://www.rti.org/publication/effects-nicotinic-receptor-partial-agonists-varenicline-cytisine-discriminative-stimulus-effects-nic Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative... of the https://www.cochrane.org/hr/evidence/CD015849_does-treatment-glp-1-receptor-agonists-prevent-complications-people-chronic-kidney-disease-and Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney... https://pmc.ncbi.nlm.nih.gov/articles/PMC11420520/ Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing... Patients undergoing axillary lymph node dissection (ALND) for breast cancer face a high risk of lymphedema, further increased by high body mass index (BMI) and... https://pmc.ncbi.nlm.nih.gov/articles/PMC3339659/ Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell... https://pmc.ncbi.nlm.nih.gov/articles/PMC12841317/ Considering Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) for Weight Loss: Insights from a... What are the main findings? Patients expressed uncertainty about eligibility, long-term safety, and treatment expectations, underscoring the need for proactive... https://pmc.ncbi.nlm.nih.gov/articles/PMC8442438/ GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of... A meta-analysis is presented of cardiovascular outcome trials (CVOTs) comparing glucagon-like peptide-1 receptor agonists (GLP-1RA) versus placebo on... https://www.ebi.ac.uk/chembl/explore/document/CHEMBL1154062 Document: Novel and potent small-molecule urotensin II receptor agonists. (CHEMBL1154062) - ChEMBL Report card for Document Novel and potent small-molecule urotensin II receptor agonists. (CHEMBL1154062). Bioorg Med Chem, A series of analogs of the... small molecule https://pmc.ncbi.nlm.nih.gov/articles/PMC10423473/ Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis... Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type... https://pmc.ncbi.nlm.nih.gov/articles/PMC13043475/ Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and... Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as breakthrough agents for weight loss. However, discontinuation is common, and clinical... https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-reports-of-diabetic-ketoacidosis-when-concomitant-insulin-was-rapidly-reduced-or-discontinued?UNLID=803528536202429105635&UNLID=724253509202473155150&UNLID=305510885202641815649 GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly... Diabetic ketoacidosis has been reported in patients with type 2 diabetes on a combination of a GLP-1 receptor agonist and insulin who had doses of concomitant... https://pmc.ncbi.nlm.nih.gov/articles/PMC10775775/ Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium glucose... Glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium glucose cotransporter 2 inhibitors (SGLT2is) have proven benefits in patients with type 2... https://theagonists.com/ The Agonists | Pharmacology of Receptor Activation & Drug Discovery TheAgonists.com explores agonist molecules in pharmacology -- receptor activation, drug design, dose-response curves, and therapeutic applications across GPCR,... the agonists pharmacology receptor activation drug https://pmc.ncbi.nlm.nih.gov/articles/PMC12303005/? The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review... https://erowid.org/references/refs_view.php?ID=7987&S=piperazine&SField=all Erowid.org: Erowid Reference 7987 : Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and... The Index page for the reference article: Chaouloff F, Laude D, Baudrie V Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma... https://www.ebi.ac.uk/chembl/explore/document/CHEMBL1146053 Document: Discovery and optimization of a novel series of liver X receptor-alpha agonists.... Report card for Document Discovery and optimization of a novel series of liver X receptor-alpha agonists. (CHEMBL1146053). Bioorg Med Chem Lett, A novel series... https://www.usitc.gov/fed_reg_notices/section_337_notices/certain_selective_thyroid_hormone_receptor_beta_122922.htm Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating... The United States International Trade Commission is an independent, nonpartisan, quasi-judicial federal agency that fulfills a range of trade-related mandates.... thyroid hormone receptor https://pmc.ncbi.nlm.nih.gov/articles/PMC7910049/ The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in... Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome... https://www.hmpgloballearningnetwork.com/site/eplab/review/glucagon-peptide-1-receptor-agonists-new-frontier-atrial-fibrillation-treatment Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Atrial Fibrillation Treatment Linda Moulton, RN, MS, reviews the characteristics of epicardial adipose tissue, its impact on atrial fibrillation, the action of glucagon-like peptide-1... https://www.endocrine.org/journals/endocrinology/effect-of-glp1-receptor-agonists-in-the-cardiometabolic-complications Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of... Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and ovulatory dysfunction. Women with PCOS have an elevated prevalence of cardiometabolic... https://www.mdedge.com/type-2-diabetes-icymi/article/267148/obesity/spending-holidays-glp-1-receptor-agonists-5-things-know Spending the Holidays With GLP-1 Receptor Agonists: 5 Things to Know | MDedge https://pmc.ncbi.nlm.nih.gov/articles/PMC11177512/ Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic... Prediabetes is a condition preceding the development of diabetes and is associated with an increased risk of a number of complications. The primary mode of... efficacy and safety https://pmc.ncbi.nlm.nih.gov/articles/PMC10892952/ Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data... Background: A potential risk of suicide associated with liraglutide or semaglutide treatments has recently emerged. Therefore, we decided to investigate the... https://pmc.ncbi.nlm.nih.gov/articles/PMC12293269/ Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder - PMC Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were originally developed for managing type 2 diabetes by enhancing insulin... https://www.questdiagnostics.com/business-solutions/life-sciences/biopharma-content-hub/the-future-of-glp-1-receptor-agonists--a-precision-medicine-appr The Future of GLP-1 Receptor Agonists: A Precision Medicine Approach | Quest Diagnostics In this webinar, the expert speaker will examine the multi-decade journey of GLP-1 receptor agonists from initial discovery to their current status as a... the future of https://pmc.ncbi.nlm.nih.gov/articles/PMC11840199/ Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based... Obesity is a global epidemic. The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric... https://pmc.ncbi.nlm.nih.gov/articles/PMC12991648/ GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized... Obesity is a complex condition marked by excessive body fat, linked to comorbidities such as type 2 diabetes and cardiovascular disease. Glucagon-like... https://www.cochrane.org/evidence/CD015849_does-treatment-glp-1-receptor-agonists-prevent-complications-people-chronic-kidney-disease-and Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney... https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1153648/full Frontiers | Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in... Aims: We performed this meta-analysis to evaluate the efficacy and safety of glucagon-like peptide-1 receptor-agonists (GLP-1RA) treatment on cardio-metaboli... https://www.aafp.org/pubs/afp/issues/2022/0700/cochrane-cardiovascular-disease.html DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People With Cardiovascular... DPP-4 inhibitors do not reduce mortality or cardiovascular outcomes in people with CVD, and they increase the risk of pancreatitis. GLP-1 receptor agonists... https://pmc.ncbi.nlm.nih.gov/articles/PMC12664052/ All-cause mortality and cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a popular first-line treatment option in managing Type 2 Diabetes Mellitus (T2DM) with cardiovascular... https://pmc.ncbi.nlm.nih.gov/articles/PMC9029608/ The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in... Insulin resistance is documented in clamp studies in 75% of women with polycystic ovary syndrome (PCOS). Although it is not included in the diagnostic criteria... the role of https://erowid.org/references/refs_view.php?ID=7987 Erowid.org: Erowid Reference 7987 : Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and... The Index page for the reference article: Chaouloff F, Laude D, Baudrie V Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma... https://pmc.ncbi.nlm.nih.gov/articles/PMC10669484/? GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media... The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for... https://elifesciences.org/articles/25492/figures Figures and data in Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal... D-serine has a major role in the regulation of NMDA receptors not only contributing to its activation as the receptors co-agonist, but also by regulating... figures and data https://www.hmpgloballearningnetwork.com/site/pulmonology/qas/rethinking-osa-management-glp-1-receptor-agonists Rethinking OSA Management With GLP-1 Receptor Agonists rethinking osa management glp receptor https://www.goodrx.com/classes/gip-receptor-glp-1-receptor-agonists Popular Gip Receptor Glp 1 Receptor Agonists List, Drug Prices and Medication Information - GoodRx Compare the cost of prescription and generic Gip Receptor Glp 1 Receptor Agonists medications. See information about popular Gip Receptor Glp 1 Receptor... https://www.ojp.gov/library/publications/transnational-perspective-evolution-synthetic-cannabinoid-receptor-agonists A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market:... This study reports toxicology-based and/or seized sample-based prevalence data relating to SCRA use in prisons from Germany, the United Kingdom (UK; Scotland... cannabinoid receptor agonists the evolution https://pmc.ncbi.nlm.nih.gov/articles/PMC25136/ Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by... The activity of l-type Ca2+ channels is increased by dihydropyridine (DHP) agonists and inhibited by DHP antagonists, which are widely used in the therapy of... https://www.ebi.ac.uk/chembl/explore/document/CHEMBL1150292 Document: 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.... Report card for Document 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. (CHEMBL1150292). J Med Chem, Research on the... https://www.sciencemediacentre.org/expert-reaction-to-observational-study-on-glp-1-receptor-agonists-and-lower-risk-of-worsening-mental-illness-as-published-in-the-lancet-psychiatry/ expert reaction to observational study on GLP-1 receptor agonists and lower risk of worsening... https://pmc.ncbi.nlm.nih.gov/articles/PMC9420816/ GLP-1, GIP and glucagon receptor poly-agonists: A new era in obesity pharmacotherapy - PMC https://pocketcasts.com/podcast/the-nafmp-pod/632d5e60-ba7c-013d-c357-024180b637c3/fueling-success-cmv-driver-nutrition-statins-and-glp-1-receptor-agonists/0e00a212-21c3-48a3-aed4-3f1804890f38 Fueling Success: CMV Driver Nutrition, Statins and GLP-1 Receptor Agonists - Pocket Casts Explored the role of nutrition and the potential use of statins and GLP-1 receptor agonists in the health and well-being of commercial motor vehicle (CMV)... https://www.usitc.gov/fed_reg_notices/section_337_notices/certain_selective_thyroid_hormone_receptor_beta_061824.htm Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating... The United States International Trade Commission is an independent, nonpartisan, quasi-judicial federal agency that fulfills a range of trade-related mandates.... thyroid hormone receptor https://tu-dresden.de/med/mf/irtg2251/research/students/investigating-the-mechanisms-of-sgtl2i-and-glp1-receptor-agonists-in-cellular-models-of-diabetic-cardiomyopathy Investigating the mechanisms of SGTL2i and GLP1 receptor agonists in cellular models of diabetic... https://pmc.ncbi.nlm.nih.gov/articles/PMC12513976/ GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome... Glucagon-Like- Peptide-1 (GLP-1) receptor agonist has an emerging role in obesity management. This meta-analysis and systematic review evaluated the... https://pmc.ncbi.nlm.nih.gov/articles/PMC6769337/ A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose... Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid... https://pmc.ncbi.nlm.nih.gov/articles/PMC10801460/ The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping... Background: Obstructive sleep apnoea (OSA) and associated hypopnoea syndromes are chronic conditions of sleep-disordered breathing with significant sequelae if... https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1464550/full Frontiers | Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in... For over seven decades, dopamine receptor 2 (D2 receptor) antagonists remained the mainstay treatment for neuropsychiatric disorders. However, it is often in... https://pmc.ncbi.nlm.nih.gov/articles/PMC12194299/ Ten Top Tips for the Management of GLP-1 Receptor Agonists in Adults within Primary Care - PMC https://www.cochrane.org/evidence/CD013650_effects-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibitors-people-cardiovascular-disease The effects of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors for people with... https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-reports-of-diabetic-ketoacidosis-when-concomitant-insulin-was-rapidly-reduced-or-discontinued?UNLID=803528536202429105635&UNLID=305510574202641811015 GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly... Diabetic ketoacidosis has been reported in patients with type 2 diabetes on a combination of a GLP-1 receptor agonist and insulin who had doses of concomitant... https://pmc.ncbi.nlm.nih.gov/articles/PMC10882716/? Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used due to their profound efficacy in glycemic control and weight management. Within... https://www.usitc.gov/fed_reg_notices/section_337_notices/certain_selective_thyroid_hormone_receptor_beta_051024.htm Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating... The United States International Trade Commission is an independent, nonpartisan, quasi-judicial federal agency that fulfills a range of trade-related mandates.... thyroid hormone receptor https://www.erowid.org/references/refs_view.php?ID=8300&S=tetralin&SField=all Erowid.org: Erowid Reference 8300 : 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential... The Index page for the reference article: Frambes NA, Kirstein CL, Moody CA, Spear LP 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral... https://pmc.ncbi.nlm.nih.gov/articles/PMC7457958/ Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists - PMC Obesity is responsible for an increased risk of sub-fecundity and infertility. Obese women show poorer reproductive outcomes regardless of the mode of... https://pmc.ncbi.nlm.nih.gov/articles/PMC12558699/ Headache and GLP-1 receptor agonists: when medications are therapeutic and when they contribute to... Obesity is a complex metabolic disorder with significant implications for both individual and public health. It has been strongly linked to chronic headache... https://pmc.ncbi.nlm.nih.gov/articles/PMC12528064/ GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain in Severe and... Patients with severe and persistent mental illness (SPMI) experience significant metabolic side effects from antipsychotic medications, including...